Literature DB >> 3463391

Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.

S Bhansali, C Karanes, W Palutke, L Crane, R Kiel, V Ratanatharathorn.   

Abstract

Fungemia caused by Trichosporon beigelii (cutaneum) has been recently recognized as a fatal infection afflicting immunocompromised patients. The authors report the case of a leukemic patient who developed splenic infection from disseminated T. beigelii. Treatment with amphotericin B, 5-fluorocytosine, and splenectomy proved successful. The etiology of disseminated T. beigelii infection, visceral seeding, and combination antifungal therapy also are discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3463391     DOI： 10.1002/1097-0142(19861015)58:8<1630::aid-cncr2820580808>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.

Authors:  E J Anaissie; R Hachem; N C Karyotakis; A Gokaslan; M C Dignani; L C Stephens; C K Tin-U
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  Disseminated trichosporonosis in a neutropenic murine model.

Authors:  D Hospenthal; T Belay; P Lappin; A Rogers; M Kennedy
Journal:  Mycopathologia       Date:  1993-05       Impact factor: 2.574

4.  Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum D-arabinitol, Candida antigen (CAND-TEC), and beta-D-glucan.

Authors:  S Morimoto; C Shimazaki; H Goto; Y Hirata; T Tasumi; N Yamagata; T Hirata; E Ashihara; T Inaba; N Fujita
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.